Skip to main content
OpenTrials
Completed

NCT Number: NCT05066529

Efficacy of Dry Needling Treatment in Myofascial Pain Syndrome

The aim of this study is to investigate the short and long-term effects of dry-needling of participants with trigger points in the upper trapezius muscle.

64 participants who diagnosed with myofascial pain syndrome will be included in the study. All participants will have trigger points in the upper trapezius muscles. They are randomised into two groups: dry needling (n=32) and exercise group (n=32). Ultrasonographic evaluation of trigger points (diameter, circumference and area), pain intensity and neck disability will be evaluated as primary outcome. Active cervical range of motion will be evaluated as secondary outcome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kanuni Sultan Suleyman Training and Research Hospital

Istanbul, 34303, Turkey (Türkiye)

About this study

Objective: The aim of this study is to investigate the short and long-term effects of dry-needling of participants with trigger points in the upper trapezius muscle.

Methods: 64 participants who diagnosed with myofascial pain syndrome will be included in the study. All participants will have trigger points in the upper trapezius muscles. They are randomised into two groups: dry needling (n=32) and exercise group (n=32). Ultrasonographic evaluation of trigger points (diameter, circumference and area), pain intensity and neck disability will be evaluated as primary outcome. Active cervical range of motion will be evaluated as secondary outcome.

All treatments will be applied by an investigator and a different blinded investigator will evaluated all participants. Numerical Rating Scale will be used for evaluating pain intensity and Neck Disability Index will be used for evaluating neck disability.

Dry-needling treatment will be applied once a week for three weeks. Servical stretching exercises are given to all participants. (20 repetitions in one session and 2 sessions in a day, three days a week.)

All participants will be evaluated before treatment, after treatment (at 3rd week) and at 3 month follow-ups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • trigger points in the upper trapezius muscle
  • 18-45 years old
  • no treatment in three months for myofascial pain syndrome (MPS)
  • accept to participate treatment program

Exclusion criteria

  • already treated in 3 months for MPS
  • below 18 years and above 45 years old
  • no acceptance to participate the trial

Treatment and study plan

dry-needling

Procedure

Dry needling is a technique in which a fine needle is used to penetrate the skin, subcutaneous tissues and muscles to mechanically disrupt tissue without the use of anesthesia. Treatment is often used to treat myofascial trigger points.

Other names: exercise

Primary outcomes

  1. diameter of trigger point

    Time frame: 3 month follow-ups

    an ultrasonographic evaluation

  2. circumference of trigger point

    Time frame: 3 month follow-ups

    an ultrasonographic evaluation

  3. area of trigger point

    Time frame: 3 month follow-ups

    an ultrasonographic evaluation

  4. Numerical Rating Scale

    Time frame: 3 month follow-ups

    a questionnaire to evaluate pain intensity

  5. Neck Disability index

    Time frame: 3 month follow-ups

    a questionnaire to evaluate neck disability

Secondary outcomes

  1. active servical range of motion

    Time frame: 3 month follow-ups

    active servical range of motion

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Official study title

Efficacy of Dry Needling Treatment in Myofascial Pain Syndrome-single Blind Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Oct 4, 2021
Registry last updated
Nov 5, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.